ERBB2 and urothelial carcinoma: Studies have shown variable results regarding the prognostic significance of HER2 expression in urothelial carcinomas, Jimenez et al. [25] studied HER2 expression by IHC in MIBC and found that irrespective of primary or nodal involvement, it was not predictive of survival.